Infectious transcripts of tick-borne encephalitis virus, generated in days by RT-PCR

被引:65
作者
Gritsun, TS [1 ]
Gould, EA [1 ]
机构
[1] INST VIROL & ENVIRONM MICROBIOL,OXFORD OX1 3SR,ENGLAND
关键词
D O I
10.1006/viro.1995.0072
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Construction of infectious clones of flaviviruses can be problematic owing to instability, toxicity, and recombination events occurring while cloning cDNA in the bacterial vectors. To overcome these difficulties we have devised a rapid and simple method for producing an infectious genetically engineered tick-borne encephalitis virus in less than 10 days using viral RNA from an unpurified virus suspension. The experimental protocol utilized the high fidelity reverse transcription-polymerase chain reaction to produce two long (5.7 and 5.2 kb) overlapping cDNA segments. To produce full-length cDNA the two overlapping segments were either ligated or fused by polymerase chain reaction. The cDNA was then transcribed and the derived full-length RNA was injected intracerebrally into young mice which reproduced the infectious virus within 8-20 days. To differentiate the engineered virus from parent virus, a Sunl restriction site was introduced by substituting nucleotides at positions 5688 and 5691 of the viral genome. This restriction site was present in the engineered virus recovered from infected mice. Antigenic and electrophoretic analysis of the proteins recovered from the engineered virus confirmed that it was indistinguishable from parent virus. In addition to its applicability as a rapid method of producing infectious engineered virus, this protocol offers the opportunity to introduce changes by site-directed mutagenesis without needing to clone the Viral DNA. The method should be applicable to most viruses possessing an infectious RNA molecule and reduces the time required to produce a genetically engineered virus from years to days. When appropriate, the choice of mice for transfection of RNA has the advantage of being extremely simple, very sensitive, and producing high titers of Stable virus. (C) 1995 Academic Press, Inc.
引用
收藏
页码:611 / 618
页数:8
相关论文
共 25 条
[1]   PCR AMPLIFICATION OF UP TO 35-KB DNA WITH HIGH-FIDELITY AND HIGH-YIELD FROM LAMBDA-BACTERIOPHAGE TEMPLATES [J].
BARNES, WM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (06) :2216-2220
[2]   INFECTIOUS TRANSCRIPTS AND CDNA CLONES OF RNA VIRUSES [J].
BOYER, JC ;
HAENNI, AL .
VIROLOGY, 1994, 198 (02) :415-426
[3]   ANTIGENIC RELATIONSHIPS BETWEEN FLAVIVIRUSES AS DETERMINED BY CROSS-NEUTRALIZATION TESTS WITH POLYCLONAL ANTISERA [J].
CALISHER, CH ;
KARABATSOS, N ;
DALRYMPLE, JM ;
SHOPE, RE ;
PORTERFIELD, JS ;
WESTAWAY, EG ;
BRANDT, WE .
JOURNAL OF GENERAL VIROLOGY, 1989, 70 :37-43
[4]   EFFECTIVE AMPLIFICATION OF LONG TARGETS FROM CLONED INSERTS AND HUMAN GENOMIC DNA [J].
CHENG, S ;
FOCKLER, C ;
BARNES, WM ;
HIGUCHI, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (12) :5695-5699
[5]  
FROLOVA TV, 1982, VOPROS VIRUSOL, V4, P89
[6]   EXAMINATION OF THE IMMUNOLOGICAL RELATIONSHIPS BETWEEN FLAVIVIRUSES USING YELLOW-FEVER VIRUS MONOCLONAL-ANTIBODIES [J].
GOULD, EA ;
BUCKLEY, A ;
CAMMACK, N ;
BARRETT, ADT ;
CLEGG, JCS ;
ISHAK, R ;
VARMA, MGR .
JOURNAL OF GENERAL VIROLOGY, 1985, 66 (JUL) :1369-1382
[7]   NUCLEOTIDE AND DEDUCED AMINO-ACID-SEQUENCE OF THE ENVELOPE GENE OF THE VASILCHENKO STRAIN OF TBE VIRUS - COMPARISON WITH OTHER FLAVIVIRUSES [J].
GRITSUN, TS ;
FROLOVA, TV ;
POGODINA, VV ;
LASHKEVICH, VA ;
VENUGOPAL, K ;
GOULD, EA .
VIRUS RESEARCH, 1993, 27 (02) :201-209
[8]   ANALYSIS OF FLAVIVIRUS ENVELOPE PROTEINS REVEALS VARIABLE DOMAINS THAT REFLECT THEIR ANTIGENICITY AND MAY DETERMINE THEIR PATHOGENESIS [J].
GRITSUN, TS ;
HOLMES, EC ;
GOULD, EA .
VIRUS RESEARCH, 1995, 35 (03) :307-321
[9]  
GRITSUN TS, 1990, VOPROS VIRUSOL, V4, P471
[10]   PREPARATIVE INVITRO MESSENGER-RNA SYNTHESIS USING SP6 AND T7 RNA-POLYMERASES [J].
GUREVICH, VV ;
POKROVSKAYA, ID ;
OBUKHOVA, TA ;
ZOZULYA, SA .
ANALYTICAL BIOCHEMISTRY, 1991, 195 (02) :207-213